181 results on '"Autophagic vacuoles"'
Search Results
2. Knockdown of the autophagy protein Beclin-1 does not affect innate cytokine production in human lung epithelial cells during respiratory syncytial virus infection
- Author
-
Parameswaran, Kavesha, Azman, Amiera Fatin, Chia, Suet Lin, Yusoff, Khatijah, and Ismail, Saila
- Published
- 2023
3. Late Effects of Ionizing Radiation on the Ultrastructure of Hepatocytes and Activity of Lysosomal Enzymes in Mouse Liver Irradiated In Vivo.
- Author
-
Łysek-Gładysińska, Małgorzata, Wieczorek, Anna, Walaszczyk, Anna, Jelonek, Karol, Pietrowska, Monika, Widłak, Piotr, Kulik, Roland, and Gabryś, Dorota
- Subjects
IONIZING radiation ,LIVER cells ,LIVER enzymes ,AUTOPHAGY ,LABORATORY mice ,HEART ,LIVER - Abstract
The study aimed to investigate late radiation-induced changes in the histology, ultrastructure, and activity of lysosomal enzymes in mouse liver exposed to ionizing radiation. The experiment was conducted on C57BL/6J male mice whose distal part of the liver was exposed occasionally to single doses of radiation (6 MV photons) during targeted heart irradiation; estimated doses delivered to analyzed tissue were 0.025 Gy, 0.25 Gy, 1 Gy, and 2 Gy. Tissues were collected 40 weeks after irradiation. We have observed that late effects of radiation have an adaptive nature and their intensity was dose-dependent. Morphological changes in hepatocytes included an increased number of primary lysosomes and autophagic vacuoles, which were visible in tissues irradiated with 0.25 Gy and higher doses. On the other hand, a significant increase in the activity of lysosomal hydrolases was observed only in tissues exposed to 2 Gy. The etiology of these changes may be multifactorial and result, among others, from unintentional irradiation of the distal part of the liver and/or functional interaction of the liver with an irradiated heart. In conclusion, we confirmed the presence of late dose-dependent ultrastructural and biochemical changes in mouse hepatocytes after liver irradiation in vivo. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
4. Perioperative melatonin: Too good to be true?
- Author
-
Smit, Marli and Currigan, Dale
- Published
- 2021
5. Late Effects of Ionizing Radiation on the Ultrastructure of Hepatocytes and Activity of Lysosomal Enzymes in Mouse Liver Irradiated In Vivo
- Author
-
Małgorzata Łysek-Gładysińska, Anna Wieczorek, Anna Walaszczyk, Karol Jelonek, Monika Pietrowska, Piotr Widłak, Roland Kulik, and Dorota Gabryś
- Subjects
ionizing radiation ,liver ,hepatocytes ,lysosomes ,autophagic vacuoles ,lysosomal hydrolases ,Microbiology ,QR1-502 - Abstract
The study aimed to investigate late radiation-induced changes in the histology, ultrastructure, and activity of lysosomal enzymes in mouse liver exposed to ionizing radiation. The experiment was conducted on C57BL/6J male mice whose distal part of the liver was exposed occasionally to single doses of radiation (6 MV photons) during targeted heart irradiation; estimated doses delivered to analyzed tissue were 0.025 Gy, 0.25 Gy, 1 Gy, and 2 Gy. Tissues were collected 40 weeks after irradiation. We have observed that late effects of radiation have an adaptive nature and their intensity was dose-dependent. Morphological changes in hepatocytes included an increased number of primary lysosomes and autophagic vacuoles, which were visible in tissues irradiated with 0.25 Gy and higher doses. On the other hand, a significant increase in the activity of lysosomal hydrolases was observed only in tissues exposed to 2 Gy. The etiology of these changes may be multifactorial and result, among others, from unintentional irradiation of the distal part of the liver and/or functional interaction of the liver with an irradiated heart. In conclusion, we confirmed the presence of late dose-dependent ultrastructural and biochemical changes in mouse hepatocytes after liver irradiation in vivo.
- Published
- 2024
- Full Text
- View/download PDF
6. Autophagic vacuolar myopathy involving the phenotype of spinocerebellar ataxia type 3.
- Author
-
Li, Jingjing, Peng, Yun, Tang, Jincai, Li, Menghua, Zhu, Min, Zhou, Meihong, Fang, Pu, and Hong, Daojun
- Subjects
- *
SPINOCEREBELLAR ataxia , *INCLUSION body myositis , *SENSORY ataxia , *AUTOPHAGY , *MUSCLE diseases , *NEMALINE myopathy - Abstract
Spinocerebellar ataxia type 3 (SCA3) is a form of autosomal dominant cerebellar ataxia with a wide range of clinical manifestations, including ataxia and pyramidal and extrapyramidal signs. A few SCA3 patients have been noticed to be predisposed to the development of inclusion body myositis. It is still unknown whether muscle can be primarily involved in the pathogenesis of SCA3. This study reported an SCA3 family in which the index patient initially presented with parkinsonism, sensory ataxia, and distal myopathy but the absence of cerebellar and pyramidal symptoms. The clinical and electrophysiological studies implied a possible combination of distal myopathy and sensory–motor neuropathy or neuronopathy. MRI muscle showed selective fat infiltration and absence of denervated edema‐like changes, indicating the distal muscle weakness had a myopathic origin. Muscle pathology showed the myopathic involvement, besides neurogenic involvement, characterized by chronic myopathic changes with multiple autophagic vacuoles. Genetic screening revealed expanded CAG of 61 repeats in the ATXN3 gene, which showed co‐segregation in the family. Besides the neurogenic origin, the myopathic origin may be partly attributed to the limb weakness of SCA3 patients, which expands the spectrum of the clinical manifestation of SCA3. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
7. Lysosomal dysfunction induced cytosolic vacuolation and increased intracellular amyloid-beta 42 (Aβ42) in human brain endothelial cells (HBEC-5i)
- Author
-
Iffah Nadiah Laili, Mohd Hamzah Mohd Nasir, Nurul Farhana Jufri, Farah Wahida Ibrahim, and Asmah Hamid
- Subjects
Amyloid angiopathy ,Alzheimer’s disease ,Autophagic vacuoles ,Lysosome inhibitor ,Neurodegenerative diseases ,Neurovascular dysfunction ,Therapeutics. Pharmacology ,RM1-950 - Abstract
Lysosome is a primary degradative organelle and is crucial in cellular homeostasis. A reduction in its function due to ageing has been associated with the development of Alzheimer's disease (AD), a common neurodegenerative disorder characterised by the deposition of neurotoxic amyloid plaque in the brain and cerebral vessel walls. The breakdown of the blood-brain barrier (BBB) plays a vital role in the pathogenesis of AD. However, the impact of lysosomal dysfunction on brain endothelial cells, the key component of the BBB, in the disease progression is yet to be fully understood. In this study, human brain endothelial cells (HBEC-5i) were exposed to a lysosomotropic compound, chloroquine (CQ) for 24 h. Cell viability was assessed with the 3-(4,5-dimethylthiazol-2-yl)− 2,5-diphenyltetrazolium bromide (MTT) assay to determine the inhibitory concentration (IC) at IC10 (17.5 µM), IC25 (70.5 µM), and IC50 (125 µM). The morphological changes observed include vacuoles arrested in the cytosols and cell shrinkage that were more prominent at IC25 and IC50. Lysosomal dysfunction was evaluated by measuring the lysosomal-associated membrane protein-1 (LAMP-1) and microtubule-associated protein light chain 3-II (LC3-II) using the capillary-based immunoassay. LC3-II was significantly increased at IC25 and IC50 (p
- Published
- 2023
- Full Text
- View/download PDF
8. Examining the role of autophagy in osteoclast function
- Author
-
Tran, Anh Nhi, Helfrich, Miep, Coxon, Fraser, and Rochford, Justin
- Subjects
616.7 ,Autophagic vacuoles ,Osteoclasts - Abstract
Osteoclasts are cells that degrade bone, by forming a ruffled border (RB) membrane, contained within an actin-rich attachment site (the sealing zone; SZ). Lysosomal vesicles fuse to the RB, and release their contents into the extracellular space to degrade bone matrix. LC3, a marker of autophagosomes, localises to the RB, implying that either canonical autophagy (i.e. autophagosomes) or non-canonical autophagy (a process where LC3 localises to non-autophagic membrane) is involved in the resorptive function of osteoclasts. To examine this in detail, this study used a model with reduced canonical autophagy (FIP200 conditional knockout mouse), and two non-canonical autophagy deficient models (Rubicon knockdown in RAW 264.7-cell derived osteoclasts and an Atg16L1 WD40 domain knockout mouse). Using advanced imaging and molecular techniques I examined whether impairing either process affected LC3 RB localisation and resorption. Reducing canonical autophagy through FIP200 deficiency did not significantly affect GFP-LC3 RB localisation or bone homeostasis. However, impairing non-canonical autophagy resulted in a trend towards increased resorption in vitro. In Atg16L1 WD40 domain-deficient osteoclasts, this may be due to the significantly larger SZs formed in the mutants, which were often stable and contained LysoTracker-positive acidic vesicles within them, putatively signalling increased resorption. As LC3 was frequently observed at the RB, I then examined the LC3-interacting lysosomal adaptor protein, PLEKHM1. I showed that in the PLEKHM1 functional knockout mouse model (R714 STOP), osteoclasts still form RBs but have impaired resorption in vitro. Detailed analysis of multiple aspects of resorption in PLEKHM1 deficient osteoclasts, was required to uncover these defects which may underlie the osteopetrotic phenotype observed in PLEKHM1 deficient mice. Overall this work reveals the potential role of non-canonical autophagy in osteoclast function. Additional dissection of this pathway in osteoclasts may uncover further new insights regarding the regulation of bone resorption and defects underlying bone disorders.
- Published
- 2018
9. Autophagy in Stem Cell Maintenance and Differentiation
- Author
-
Bhupendra V. Shravage, Kursad Turksen, Bhupendra V. Shravage, and Kursad Turksen
- Subjects
- Cell differentiation, Stem cells, Autophagic vacuoles
- Abstract
This book covers a wide range of topics that illustrate the various functions of autophagy in stem cells and offers insights on the mechanisms by which autophagy can regulate stem-cell self-renewal and facilitate specific differentiation programs. Stem cells are unique cells present in most multicellular animals and are essential for their survival. They have two unique properties: the ability to self-renew and the ability to differentiate into one or more cell types. These characteristics of stem cells have found immense therapeutic potential in regenerative medicine. Autophagy is a crucial membrane trafficking pathway that is essential for maintaining cellular homeostasis that involves sequestration of non-functional proteins, protein aggregates and damaged organelles in double-membraned vesicles called autophagosomes, which are subsequently targeted to the lysosome for degradation. The primary aim of this book is to provide knowledge of recent developments in our understanding of the role of autophagy in stem cells, including germline stem cells.Autophagy is considered a promising target for many diseases. Significant efforts are being developed to identify specific modulators of autophagy, which will aid in designing combinatorial therapeutic strategies that will allow significant improvements in regenerative medicine.
- Published
- 2023
10. A 42-Year-Old Woman with Progressive Limb Weakness and Breathing Difficulty
- Author
-
Zhou, Lan, Burns, Dennis K., Zhou, Lan, editor, Burns, Dennis K., editor, and Cai, Chunyu, editor
- Published
- 2020
- Full Text
- View/download PDF
11. Autophagy in Health and Disease
- Author
-
Beverly Rothermel, Abhinav Diwan, Beverly Rothermel, and Abhinav Diwan
- Subjects
- Homeostasis, Autophagic vacuoles
- Abstract
Autophagy in Health and Disease, Second Edition provides a comprehensive overview of the process of autophagy and its impact on human physiology and pathophysiology. It expands on the scope of the first edition by covering a wider range of cell types, developmental processes, and organ systems. The second edition is an international effort by investigators from 15 different countries whose many contributions are comprised in 28 chapters organized into six sections. The first section (Chapters 1-7) covers foundational concepts, including history, trajectory of the research field, mechanisms of autophagy, and autophagy regulation. The second section (Chapters 8-11) details developmental aspects, including stem cells, embryogenesis, hematopoiesis, and paligenosis. The subsequent sections are devoted to the role of autophagy in specific organ systems involved in metabolic control and diabetes (Chapters 12-15), the cardiovascular system (Chapters 16-18), and the nervous system (Chapters 19-20). The final section (Chapters 21-28) addresses autophagy in other organ systems vital to human health and longevity. Also included are chapters on microautophagy, chaperone-mediated autophagy, and the potential for autophagy as a therapeutic target.Autophagy in Health and Disease is invaluable to anyone new to the field as well as established investigators looking for a broader understanding of autophagy from outside their specific field of study. - Provides a comprehensive overview of the process of autophagy and its impact on human physiology and pathology - Offers extended coverage of the mechanisms that mediate autophagy - Covers the role of autophagy in stem cells and induced pluripotent stem cells, as well as the regenerative process of paligenosis - Highlights important questions that remain to be addressed
- Published
- 2021
12. Non-Canonical Autophagy : Mechanisms and Pathophysiological Implications
- Author
-
Giulia Petroni, Lorenzo Galluzzi, Giulia Petroni, and Lorenzo Galluzzi
- Subjects
- Autophagic vacuoles
- Abstract
Non-canonical Autophagy: Mechanisms and Pathophysiological Implications outlines the differences between'canonical'and'non-canonical'forms of autophagy, highlighting the discoveries concerning the molecular mechanisms underlying these unconventional forms of autophagy and the advancements in pathophysiological features of'non-canonical'autophagy. The book discusses all forms of'non-canonical'autophagy and the complexity of autophagy-dependent cell death. Readers will gain a better understanding of mechanisms underlying'non-canonical'autophagy so that they can interpret the biological effects of autophagy correctly and identify reliable, novel and effective treatment strategies. - Presents the most advanced information surrounding the molecular mechanisms underlying non-canonical autophagy - Outlines the increasing evidence regarding the involvement of non-canonical autophagy in multiple physiological and pathological processes - Discusses the therapeutic potential of autophagy modulators and the obstacles that have limited their development
- Published
- 2021
13. Autophagy and Senescence in Cancer Therapy
- Author
-
Paul B. Fisher, David A. Gewirtz, Paul B. Fisher, and David A. Gewirtz
- Subjects
- Cancer--Age factors, Aging, Cells--Aging, Cancer--Treatment, Autophagic vacuoles
- Abstract
Advances in Cancer Research, Volume 150, the latest release in this ongoing series, covers the relationship(s) between autophagy and senescence, how they are defined, and the influence of these cellular responses on tumor dormancy and disease recurrence. Specific sections in this new release include Autophagy and senescence, converging roles in pathophysiology, Cellular senescence and tumor promotion: role of the unfolded protein response, autophagy and senescence in cancer stem cells, Targeting the stress support network regulated by autophagy and senescence for cancer treatment, Autophagy and PTEN in DNA damage-induced senescence, mTOR as a senescence manipulation target: A forked road, and more. - Addresses the relationship between autophagy and senescence in cancer therapy - Covers autophagy and senescence in tumor dormancy - Explores autophagy and senescence in disease recurrence
- Published
- 2021
14. Novel autophagy regulators that affect polyglutamine pathology in Drosophila
- Author
-
Huseynova, Gunel
- Subjects
576.5 ,Autophagic vacuoles ,Nervous system--Degeneration ,Drosophila - Published
- 2016
15. Autophagy in Health and Disease
- Author
-
Lorenzo Galluzzi, Aitziber Buque, Lorenzo Galluzzi, and Aitziber Buque
- Subjects
- Autophagic vacuoles, Homeostasis
- Abstract
Autophagy in Health and Disease, Volume 175, presents the latest insights from renowned experts in the field who discuss the key role of autophagic responses in the preservation of cellular and organismal homeostasis and how defects in the molecular apparatus for autophagy drive or accompany disease. Specific chapters in this new release include Crosstalk between autophagy and cell death signaling: mechanisms and therapeutic relevance, C. elegans to model autophagy-related human disorders, Autophagy in Kidney Disease: advances and therapeutic potential, Autophagy in Chronic Lung Disease, Autophagy in motoneuronal disorders, Strategies employed by viruses to manipulate autophagy, and much more. - Provides an outstanding panel of recognized experts in the field who discuss the latest in autophagy - Includes critical discussions of autophagy in the context of each major human disorder - Models autophagy-related human pathologies in lower eukaryotes
- Published
- 2020
16. The Switch : Ignite Your Metabolism with Intermittent Fasting, Protein Cycling, and Keto
- Author
-
James W. Clement, Kristin Loberg, James W. Clement, and Kristin Loberg
- Subjects
- Ketone body metabolism, Metabolism, Autophagic vacuoles, Health, Lysosomes--Metabolism
- Abstract
How can you lose weight, ease chronic conditions, and stay healthier longer? Discover how to “rewrite your health destiny” (David Perlmutter, MD, #1 New York Times bestselling author of Grain Brain) with this accessible book that teaches you how to flip the switch on your metabolism with intermittent fasting, protein cycling, and keto. Within each of us is an ancient mechanism that eliminates toxic materials, initiates fat burning, and protects cells from becoming dysfunctional—or turning cancerous. It's called autophagy, and when it's turned on, the complex operation not only can slow down the aging process, it can optimize biological function as a whole, helping to stave off all manner of diseases and affording us the healthy life spans we never thought possible. It's the body's ultimate switch to life. So how can we positively activate this switch? How frequently should we fast and for how long? Which foods dial up autophagy or, conversely, turn it down? How much exercise and what types are recommended? What's the sweet spot between intermittent fasting, protein cycling, and ketogenic eating? Backed by a wealth of scientific data and featuring a gallery of guidelines to follow for lasting results, “The Switch offers a paradigm shift in the way we think about health—and how to avoid decline and illness. This is a must read” (Mark Hyman, #1 New York Times bestselling author).
- Published
- 2019
17. ER stress converts autophagy defects into intestinal inflammation
- Author
-
Adolph, Timon Erik
- Subjects
610 ,Genetics ,Endoplasmic reticulum ,Autophagic vacuoles ,Inflammatory bowel diseases - Published
- 2015
18. Pathological mitochondria in neurons and perivascular astrocytic endfeet of idiopathic normal pressure hydrocephalus patients
- Author
-
Md Mahdi Hasan-Olive, Rune Enger, Hans-Arne Hansson, Erlend A. Nagelhus, and Per Kristian Eide
- Subjects
Mitochondria ,Mitophagy ,Endoplasmic reticulum ,Autophagic vacuoles ,Neurons ,Astrocytes ,Neurology. Diseases of the nervous system ,RC346-429 - Abstract
Abstract Background A growing body of evidence suggests that the accumulation of amyloid-β and tau (HPτ) in the brain of patients with the dementia subtype idiopathic normal pressure hydrocephalus (iNPH) is associated with delayed extravascular clearance of metabolic waste. Whether also clearance of intracellular debris is affected in these patients needs to be examined. Hypothetically, defective extra- and intra-cellular clearance of metabolites may be instrumental in the neurodegeneration and dementia characterizing iNPH. This study explores whether iNPH is associated with altered mitochondria phenotype in neurons and astrocytes. Methods Cortical brain biopsies of 9 reference (REF) individuals and 30 iNPH patients were analyzed for subcellular distribution and morphology of mitochondria using transmission electron microscopy. In neuronal soma of REF and iNPH patients, we identified normal, pathological and clustered mitochondria, mitochondria-endoplasmic reticulum contact sites and autophagic vacuoles. We also differentiated normal and pathological mitochondria in pre- and post-synaptic nerve terminals, as well as in astrocytic endfoot processes towards vessels. Results We found a high prevalence of pathological mitochondria in neuronal soma and pre- and post-synaptic terminals, as well as increased mitochondrial clustering, and altered number of mitochondria-endoplasmic reticulum contact sites in iNPH. Non-fused autophagic vacuoles were more abundant in neuronal soma of iNPH patients, suggestive of cellular clearance failure. Moreover, the length of postsynaptic densities was reduced in iNPH, potentially related to reduced synaptic activity. In astrocytic endfoot processes, we also found increased number, area and area fraction of pathological mitochondria in iNPH patients. The proportion of pathological mitochondria correlated significantly with increasing degree of astrogliosis and reduced perivascular expression of aquaporin-4 (AQP4), assessed by light microscopy immunohistochemistry. Conclusion Our results provide evidence of mitochondrial pathology and signs of impaired cellular clearance in iNPH patients. The results indicate that iNPH is a neurodegenerative disease with close similarity to Alzheimer’s disease.
- Published
- 2019
- Full Text
- View/download PDF
19. Autophagy and Cardiometabolic Diseases : From Molecular Mechanisms to Translational Medicine
- Author
-
Jun Ren, James R. Sowers, Yingmei Zhang, Jun Ren, James R. Sowers, and Yingmei Zhang
- Subjects
- Cardiovascular system--Diseases--Molecular aspects, Cardiovascular system--Diseases, Autophagic vacuoles
- Abstract
Autophagy and Cardiometabolic Diseases: From Moleculer Mechanisms to Translational Medicine covers the science of autophagy in relation to cardiometabolic diseases and the future therapeutic potentials of autophagy regulation in these processes. Processes are not described in isolation, but in concert with other cellular and/or metabolic processes, such as lipogenesis, glucose, energy metabolism and apoptosis. This approach recognizes the multifactorial nature of cardiometabolic diseases, including obesity, diabetes, insulin resistance, hypertension and dyslipidemia. The book provides explanations, while also distinguishing the delicate role for autophagy in pathogenesis and exploring complications for cardiometabolic diseases. By targeting autophagy, it offers new avenues for drug discovery and treatment for cardiometabolic anomalies. It is a perfect resource for cardiology researchers, scientists and medical practitioners. - Explains the processes inherent in the protein quality control for pathogenesis and complications of cardiometabolic diseases - Provides knowledge from internationally recognized contributors in the field - Incorporates a translational approach, covering the basic cellular biology of autophagy and presenting the role of autophagy regulation for both pathogenesis and complication in cardiometabolic diseases - Contains access to a companion website with additional illustrations
- Published
- 2018
20. Autophagy in Health and Disease : Potential Therapeutic Approaches
- Author
-
Kursad Turksen and Kursad Turksen
- Subjects
- Cytology, Cell death, Autophagic vacuoles
- Abstract
This timely volume explores the impact of autophagy in various human diseases, emphasizing the cell biological aspects and focusing on therapeutic approaches to these diseases. The chapters cover autophagy and its potential applications on diseases ranging from obesity, osteoarthritis, pulmonary fibrosis, and inflammation, through ALS, Parkinson's, retinal degeneration, breast cancer, alcoholic liver disease and more. The final chapters round out the book with a discussion of autophagy in drug discovery and'bench to bedside'. Chapters are contributed by leading authorities and describe the general concepts of autophagy in health and disease, marrying cell biology and pharmacology and covering: studies derived from preclinical experiments, manufacturing considerations,and regulatory requirements pertaining to drug discovery and manufacturing and production. This volume will be useful for basic scientists as well as already practicing cliniciansand advanced graduate students.
- Published
- 2018
21. Investigating the link between cancer-related genes and autophagy
- Author
-
Toh, Pei Chern Pearl
- Subjects
610 ,Oncogenes ,Antioncogenes ,Autophagic vacuoles - Published
- 2014
22. Autophagy: Cancer, Other Pathologies, Inflammation, Immunity, Infection, and Aging
- Author
-
M. A. Hayat and M. A. Hayat
- Subjects
- Cytology, Autophagic vacuoles, Cell death
- Abstract
Autophagy: Cancer, Other Pathologies, Inflammation, Immunity, Infection, and Aging is an eleven volume series that discusses in detail all aspects of autophagy machinery in the context of health, cancer, and other pathologies. Autophagy maintains homeostasis during starvation or stress conditions by balancing the synthesis of cellular components and their deregulation by autophagy. This series discusses the characterization of autophagosome-enriched vaccines and its efficacy in cancer immunotherapy. Autophagy serves to maintain healthy cells, tissues, and organs, but also promotes cancer survival and growth of established tumors. Impaired or deregulated autophagy can also contribute to disease pathogenesis. Understanding the importance and necessity of the role of autophagy in health and disease is vital for the studies of cancer, aging, neurodegeneration, immunology, and infectious diseases. Comprehensive and forward-thinking, these books offer a valuable guide to cellular processes while also inciting researchers to explore their potentially important connections. - Presents the most advanced information regarding the role of the autophagic system in life and death - Examines whether autophagy acts fundamentally as a cell survivor or cell death pathway or both - Introduces new, more effective therapeutic strategies in the development of targeted drugs and programmed cell death, providing information that will aid in preventing detrimental inflammation - Features recent advancements in the molecular mechanisms underlying a large number of genetic and epigenetic diseases and abnormalities, including atherosclerosis and CNS tumors, and their development and treatment - Includes chapters authored by leaders in the field around the globe—the broadest, most expert coverage available
- Published
- 2017
23. Molecular Characterization of Autophagic Responses Part B
- Author
-
Lorenzo Galluzzi, Guido Kroemer, Jose Manuel Bravo-San Pedro, Lorenzo Galluzzi, Guido Kroemer, and Jose Manuel Bravo-San Pedro
- Subjects
- Cell death, Cytology, Autophagic vacuoles
- Abstract
Molecular Characterization of Autophagic Responses, Part B presents a collection of methods for the qualitative and quantitative evaluation of virtually all the morphological, biochemical, and functional manifestations of autophagy, in vitro, ex vivo and in vivo, in organisms as distant as yeast and man. Autophagy is an evolutionarily conserved mechanism for the lysosomal degradation of superfluous or dangerous cytoplasmic entities, and plays a critical role in the preservation of cellular and organismal homeostasis. Monitoring the biochemical processes that accompany autophagy is fundamental for understanding whether autophagic responses are efficient or dysfunctional. - Offers a detailed overview of the protocols used to study autophagy and various aspects of autophagic responses - Written in an accessible style by renowned experts in the field
- Published
- 2017
24. Molecular Characterization of Autophagic Responses Part A
- Author
-
Lorenzo Galluzzi, Guido Kroemer, Jose Manuel Bravo-San Pedro, Lorenzo Galluzzi, Guido Kroemer, and Jose Manuel Bravo-San Pedro
- Subjects
- Cell death, Cytology, Autophagic vacuoles
- Abstract
Molecular Characterization of Autophagic Responses, Part A, presents a collection of methods for the qualitative and quantitative evaluation of virtually all the morphological, biochemical, and functional manifestations of autophagy, in vitro, ex vivo and in vivo, in organisms as distant as yeast and man. Autophagy is an evolutionarily conserved mechanism for the lysosomal degradation of superfluous or dangerous cytoplasmic entities, and plays a critical role in the preservation of cellular and organismal homeostasis. Monitoring the biochemical processes that accompany autophagy is fundamental for understanding whether autophagic responses are efficient or dysfunctional. - Offers a detailed overview of the protocols used to study autophagy and various aspects of autophagic responses - Written in an accessible style by renowned experts in the field
- Published
- 2017
25. Autophagy: Cancer, Other Pathologies, Inflammation, Immunity, Infection, and Aging : Volume 12
- Author
-
M. A. Hayat and M. A. Hayat
- Subjects
- Cytology, Autophagic vacuoles, Cell death
- Abstract
Autophagy: Cancer, Other Pathologies, Inflammation, Immunity, Infection, and Aging, Volume 12 discusses and details almost all aspects of the autophagy machinery in the context of health, cancer and other pathologies. Autophagy is more widely accepted as beneficial given its role in eliminating'toxic assets'and promoting cell viability, hence, it has emerged as a new and potent modulator of disease progression that is both scientifically intriguing and clinically relevant. As the latest release in the Autophagy book series, users will find a detailed explanation of the role of molecular mechanisms. - Presents the most advanced information regarding the role of the autophagic system in life and death - States recent advancements in the molecular mechanisms underlying a large number of genetic and epigenetic diseases and abnormalities - Summarizes the most up-to-date findings on how autophagy is executed and regulated at the molecular level and how its disruption can lead to disease - Authored by global leaders in the field, bringing the broadest, most expert coverage available
- Published
- 2017
26. Accumulation of neutral lipids in dystrophic neurites surrounding amyloid plaques in Alzheimer's disease.
- Author
-
Huang, Hao, Sharoar, Md Golam, Pathoulas, Joseph, Fan, Liangliang, He, Wanxia, Xiang, Rong, and Yan, Riqiang
- Subjects
- *
ALZHEIMER'S disease , *AMYLOID plaque , *HEAT shock proteins , *NEURONS , *AUTOPHAGY , *LIPIDS - Abstract
Alzheimer's disease (AD) is characterized by the formation β-amyloid (Aβ) deposited neuritic plaques. Recent evidence suggests that abnormal lipid metabolism and accumulation could serve as biomarkers for neurodegenerative diseases, including AD. Tubular endoplasmic reticulum protein, reticulon 3 (RTN3), plays a crucial role in the development of neuritic plaque and lipid metabolism in AD brains. In present study, we sought to investigate a potential association between neutral lipid accumulation and AD pathology. BODIPY 500/510 dye was used to label neutral lipid surrounding Aβ plaques in APPNL-G-F mouse and AD postmortem brains samples. Immunofluorescent images were captured using confocal microscope and co-localization between lipid metabolism proteins and neutral lipids were evaluated. Lipid accumulation in Aβ plaque surrounding dystrophic neurites (DNs) was observed in the cortical region of AD mouse models and human AD brain samples. The neutral lipid staining was not co-localized with IBA1-labeled microglia or GFAP-labeled astrocytes, but it was co-labeled with VAMP2 and neurofilament. We further showed that neutral lipids were accumulated in RTN3 immunoreactive DNs. Both the neutral lipids accumulation and RIDNs formation showed age-dependent patterns in surrounding amyloid plaques. Mechanistic studies revealed that RTN3 likely contributes to the enrichment of neutral lipids near plaques by interacting with heat shock cognate protein 70 (HSC70) and diminishing its function in chaperone-mediated lipophagy. Our study provides immunohistochemical evidence of neutral lipids being enriched in DNs near amyloid plaques. Our findings shed light on RTN3-mediaed lipid accumulation in AD neuropathology and provide fresh insights into the role of RTN3 in neurodegenerative diseases. Potential mechanism of how a deficiency in RTN3 induces larger BODIPY+ DNs and amyloid plaques in Alzheimer's disease. The absence of RTN3 could alleviate the interaction between RTN3 and HSC70. This, in turn, would potentiate the regulatory capacity of HSC70 over lipophagy and lipolysis, furnishing numerous autophagic vacuoles with membrane components. This cascade of events holds the potential to stimulate the augmented production and subsequent release of Aβ peptides and tau protein. [Display omitted] • Neutral lipids were accumulated in dystrophic neurites near amyloid plaques of AD brain. • RTN3 immunoreative dystrophic neurites-associated neutral lipid accumulation is an age-dependent occurrence. • RTN3 contribute to the enrichment of neutral lipids in plaques by diminishing chaperone-mediated autophagy. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
27. The role of autophagy in the pathogenesis of Paget's disease of bone
- Author
-
Azzam, Eman
- Subjects
610 ,Osteitis deformans ,Autophagic vacuoles - Abstract
Paget's disease of bone (PDB) is characterised by focal lesions of increased bone turnover driven by overactive osteoclasts, which often contain nuclear and cytoplasmic inclusion bodies. Mutations affecting the sequestosome-1 (SQSTM1) ubiquitin-associated (UBA) domain have been identified in individuals with PDB. SQSTM1, also known as p62, is a ubiquitously expressed multidomain scaffold protein of 62 kDa that functions in multiple signalling pathways important for cell survival and osteoclast activity. The mechanisms by which SQSTM1 mutations cause PDB remain unclear. Using immunohistochemistry, I showed evidence that protein degradation pathway components, both from the UPS and the autophagy pathway, are elevated in osteoclasts in patients with PDB compared with control osteoclasts from patients without PDB. Using molecular and microscopical methods to examine Pagetic bone biopsies, osteoclast cultures and various cell lines, I have identified two isoforms of SQSTM1. In all cell types examined, four SQSTM1 transcripts were detected, differing in their 5′-untranslated region; one transcript encodes p62, while the other three encode a 55 kDa isoform of SQSTM1. The newly identified isoform also contains the UBA domain mutated in PDB. Using biochemical and microscopical methods, I found that both SQSTM1 isoforms are degraded by autophagy. The isoforms interact with each other and form aggregates upon autophagy inhibition. SQSTM1-55 is ~21× more abundant in osteoclasts than SQSTM1/p62. Biochemical and microscopical methods showed that PDB-causing mutations in SQSTM1/p62 impair its autophagic degradation. Cell lines expressing SQSTM1/p62 mutations form paracrystalline inclusion bodies that by immuno-transmission electron microscopy (TEM) were found to contain SQSTM1 and ubiquitin and were ultrastructurally identical to those found in PDB. As observed by TEM, these inclusions can be degraded by autophagy. The effects of mutations in SQSTM1-55 have yet to be characterised. Abstract Taken together, these data show that mutations in SQSTM1 isoforms impair protein degradation and can lead to inclusion body formation suggesting that PDB results from dysregulated protein degradation in osteoclasts.
- Published
- 2013
28. Autophagy Networks in Inflammation
- Author
-
Maria Chiara Maiuri, Daniela De Stefano, Maria Chiara Maiuri, and Daniela De Stefano
- Subjects
- Cell death, Autophagic vacuoles, Inflammation
- Abstract
Autophagy principally serves an adaptive function to protect organisms against diverse human pathologies, including cancer and neurodegeneration. Recent developments using in vitro, ex vivo and in vivo models show the involvement of the autophagy pathway in immunity and inflammation. Moreover, direct interactions between autophagy proteins and immune signalling molecules have also been demonstrated. Defects in autophagy - similar to cancer, neurodegenerative diseases and aging - through autophagy gene mutation and/or microbial antagonism, may underlie the pathogenesis of many infectious diseases and inflammatory syndromes. In spite of the increasing awareness of the importance of autophagy in these pathophysiological conditions, this process remains underestimated and is often overlooked. As a consequence, its role in the initiation, stability, maintenance, and progression of these diseases are still poorly understood. This book reviews the recent advances regarding the functions ofthe autophagy pathway and autophagy proteins in immunity and inflammation, focusing on their role in self-nonself distinction, their implications in innate and adaptive immune responses and their dysregulation in the pathology of certain inflammatory and autoimmune diseases.
- Published
- 2016
29. Autophagy: Cancer, Other Pathologies, Inflammation, Immunity, Infection, and Aging : Volume 8- Human Diseases
- Author
-
M. A. Hayat and M. A. Hayat
- Subjects
- Autophagic vacuoles
- Abstract
Volume 8 Autophagy and Human Diseases, concentrates on the role of Autophagy in human diseases, including tumorigenesis. The diseases discussed include melanoma, liver cancer, pancreatic cancer, and neurodegenerative disorders. Loss of autophagy in the central nervous system causes neurodegeneration (Alzheimers disease, Huntington's disease, Parkin's disease, and Amyotrophic Lateral Sclerosis). Melanoma is one of the most serious diseases in humans. Autophagy plays a key role in the anticancer response to Chemotherapy. However, autophagy can increase or decrease the effectiveness of chemotherapy. The reasons for these contradictory effects are explained. Autophagy also plays a role in idiopathic inflammatory diseases, infection, and immunity. An explanation is given how autophagy is closely linked to control of innate and adaptive immune responses in host defense in part by regulating cytokine production. The role of autophagy in cutaneous malignant melanoma is discussed in detail and expression of Beclin 1 and LC3 autophagic genes in melanoma is included to explain the molecular mechanisms underlying this very serious disease, which tends to metastasize to the brain. The effect of the treatment of this disease using Terfenadine through the induction of autophagy and apoptosis is also included. Autophagy and apoptosis are two main mechanisms involved in programmed cell death. - Presents the most advanced information regarding the role of the autophagic system in life and death and whether autophagy acts fundamentally as a cell survivor, or cell death pathway, or both - Introduces new, more effective therapeutic strategies, in the development of targeted drugs and programmed cell death, providing information that will aid on preventing detrimental inflammation - States recent advancements in the molecular mechanisms underlying a large number of genetic and epigenetic diseases and abnormalities
- Published
- 2016
30. Autophagy: Cancer, Other Pathologies, Inflammation, Immunity, Infection, and Aging : Volume 10
- Author
-
M. A. Hayat and M. A. Hayat
- Subjects
- Cell death, Autophagic vacuoles
- Abstract
Autophagy: Cancer, Other Pathologies, Inflammation, Immunity, Infection, and Aging, Volume 10 offer a valuable guide to both cellular processes, while encouraging researchers to explore their potentially important connections. Autophagy serves to maintain healthy cells, tissues, and organs, but also promotes cancer survival and growth of established tumors. Impaired or deregulated autophagy can also contribute to disease pathogenesis. This is the tenth volume of the multivolume series that discusses, in detail, almost all aspects of the autophagy machinery in the context of health, cancer, and other pathologies. Autophagy maintains homeostasis during starvation or stress conditions by balancing the synthesis of cellular components and their deregulation by autophagy. Volume 10 of the Autophagy series discusses the role of a novel binuclear palladacycle complex that inhibits melanoma growth through apoptosis and autophagy. - Presents the most advanced information regarding the role of the autophagic system in life and death - Contains a direct focus on the role of a novel binuclear palladacycle complex that inhibits melanoma growth - Introduces new, more effective therapeutic strategies in the development of targeted drugs and programmed cell death, providing information that will aid in preventing detrimental inflammation - States recent advancements in the molecular mechanisms underlying a large number of genetic and epigenetic diseases and abnormalities - Edited work with chapters authored by leaders in the field from around the globe—the broadest, most expert coverage available
- Published
- 2016
31. Targeting Autophagy in Cancer Therapy
- Author
-
Jin-Ming Yang and Jin-Ming Yang
- Subjects
- Cancer cells, Cancer--Molecular aspects, Cancer--Treatment, Autophagic vacuoles
- Abstract
This volume will detail the current state and perspectives of autophagy-based cancer therapy. Covering a wide range of topics, it will include an overview of autophagy as a therapeutic target in cancer, autophagy modulators as cancer therapeutic agents, implications of micro-RNA-regulated autophagy in cancer therapy, modulation of autophagy through targeting PI3 kinase in cancer therapy, targeting autophagy in cancer stem cells, and roles of autophagy in cancer immunotherapy. In addition, the volume will review applications of system biology and bioinformatics approaches to discovering cancer therapeutic targets in the autophagy regulatory network. The volume will be beneficial for a variety of basic and clinical scientists, including cancer biologists, autophagy researchers, pharmacologists, and clinical oncologists who wish to delve more deeply into this field of cancer research.This volume will be the first book to focus solely on autophagy as a target in cancer therapy. As well, it will comprehensively discuss the roles of autophagy in most currently available cancer treatments.
- Published
- 2016
32. Autophagy: Cancer, Other Pathologies, Inflammation, Immunity, Infection, and Aging : Volume 9: Human Diseases and Autophagosome
- Author
-
M. A. Hayat and M. A. Hayat
- Subjects
- Autophagic vacuoles
- Abstract
Autophagy: Cancer, Other Pathologies, Inflammation, Immunity, Infection, and Aging: Volume 9: Human Diseases and Autophagosome offers a valuable guide to both cellular processes while helping researchers explore their potentially important connections. Volume 9 emphasizes the role of autophagy in diseases, such as leukemia, antifungal and antibacterial immunity, and transplantation. This volume also explains, in detail, the molecular mechanism(s) underlying the formation of autophagosomes, including the progression of omegasomes to autophagosomes. This information is important because one of the major functions of autophagy is to degrade and eliminate excessive, old, and harmful materials from the cell. Autophagosomes receive these materials (cellular cargo) and transport them to lysosomes for degradation. Lysosomes contain the digestive enzymes (hydrolases) that breakdown proteins, lipids, carbohydrates, etc. (self-digestion). To further explain this phenomenon, the role of the endoplasmic reticulum (ER) in the formation of autophagosomes is discussed. ULK1 and Beclin 1 proteins are also important in the initial formation of autophagosomes, and are also discussed. Because much of the early research in this area was carried out using yeast cells, the role of Golgi complex in the autophagosome formation in these cells is explained. This volume also includes an explanation of the role of the autophagy-related gene ATG5 in cancer (e.g., gastrointestinal cancer). Paradoxically, autophagy is a'double-edged sword because it eliminates some pathogens, whereas it can be used by some intracellular pathogens to multiply and cause infection. This book is an asset to newcomers, providing a concise overview of the role of autophagy in necrosis and inflammation, while also serving as an excellent reference for more experienced scientists and clinicians. - Presents the most advanced information regarding the role of the autophagic system in life and death - emphasizes autophagy in diseases, such as leukemia - Introduces new, more effective therapeutic strategies in the development of targeted drugs and programmed cell death, providing information that will aid in preventing detrimental inflammation - States recent advancements in the molecular mechanisms underlying a large number of genetic and epigenetic diseases and abnormalities - Edited work with chapters authored by leaders in the field from around the globe—the broadest, most expert coverage available
- Published
- 2016
33. The genetics of Crohn's disease : exploring the contribution of autophagy variants and PRDM1/BLIMP1
- Author
-
Zhang, Hu
- Subjects
610 ,Autophagic vacuoles ,Crohn's disease--Genetic aspects - Published
- 2012
34. The roles of NDP52 and LC3C in anti-bacterial autophagy
- Author
-
von Muhlinen, Natalia
- Subjects
610 ,Autophagic vacuoles - Published
- 2012
35. Effect of canola oil on ultrastructure of testis in adult male albino rat.
- Author
-
Hashish, Hagar A.
- Subjects
CANOLA oil ,INFERTILITY treatment ,DISEASE incidence ,SPERMATOGENESIS ,MONOUNSATURATED fatty acids ,SERTOLI cells - Abstract
Copyright of African Journal of Biological Sciences is the property of African Journal of Biological Sciences and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
- Published
- 2021
- Full Text
- View/download PDF
36. Autophagy: Cancer, Other Pathologies, Inflammation, Immunity, Infection, and Aging : Volume 7- Role of Autophagy in Therapeutic Applications
- Author
-
M. A. Hayat and M. A. Hayat
- Subjects
- Cell death, Autophagic vacuoles, Diseases--Treatment, Therapeutics
- Abstract
Understanding the importance and necessity of the role of autophagy in health and disease is vital for the studies of cancer, aging, neurodegeneration, immunology, and infectious diseases. Comprehensive and up-to-date, this book offers a valuable guide to these cellular processes whilst inciting researchers to explore their potentially important connections. Volume 7 provides coverage of the latest developments in autophagosome biogenesis and regulation; the role of autophagy in protein quality control; and the role of autophagy in apoptosis. Attention is given to autophagy in the cardiovascular system, with particular insights into the role of autophagy in atherosclerosis and the distinctive behavior of autophagy in the sinoatrial node. Cutting-edge findings in the relationships between autophagy and lifestyle are explored with the regulation of macroautophagy in response to exercise, as well as the promotion of carcinogenesis via autophagy in response to cigarette smoking. Volume 7 highlights the importance of understanding the role of autophagy in context, as the complexity of autophagic function becomes increasingly clear. Autophagy may be differentially regulated, and may perform distinctive cell-specific functions even within a single tissue. The overall significance of autophagy thus cannot be oversimplified, and must be explored with granular detail of the specific role, function, and area of impact.This book is an asset to newcomers as a concise overview of the complex significance of autophagy, while serving as an excellent reference for more experienced scientists and clinicians looking to update their knowledge. Volumes in the Series
- Published
- 2015
37. Autophagy: Cancer, Other Pathologies, Inflammation, Immunity, Infection, and Aging : Volume 6- Regulation of Autophagy and Selective Autophagy
- Author
-
M. A. Hayat and M. A. Hayat
- Subjects
- Natural immunity, Autophagic vacuoles, Cell death, Lysosomes--Physiology
- Abstract
Volume 6 provides coverage of the mechanisms of regulation of autophagy; intracellular pathogen use of the autophagy mechanism; the role of autophagy in host immunity; and selective autophagy. Attention is given to a number of mechanistic advances in the understanding of regulation, particularly the importance of nutrient availability; microRNAs; and cross-talk with other protein degradation pathways. Intracellular pathogen repurposing of autophagy for pathogenic benefit is also provided, with coverage of Herpesvirus protein modulation of autophagy; the varicella-zoster virus and the maintenance of homeostasis; and the relationship between autophagy and the hepatitis b virus. The significance of autophagy in host defense is elucidated, providing a specific focus on facilitation of antigen presentation; participation in thymic development; and the sharing of regulatory nodes with innate immunity. Selective autophagy for the degradation of mitochondria and endocytosed gap junctions are also explored. This book is an asset to newcomers as a concise overview of the regulation of autophagy, its role in host defense and immunity, and selective autophagy, while serving as an excellent reference for more experienced scientists and clinicians looking to update their knowledge. Volumes in the Series
- Published
- 2015
38. Autophagy, Infection, and the Immune Response
- Author
-
William T. Jackson, Michele S. Swanson, William T. Jackson, and Michele S. Swanson
- Subjects
- Immune system, Natural immunity, Autophagic vacuoles, Immune response
- Abstract
The relationship between infection and immunity and autophagy, a pathway of cellular homeostasis and stress response, has been a rapidly growing field of study over the last decade. While some cellular processes are pro- or anti-infection, autophagy has been proven to be both: a part of the innate immune response against some microbes, and a cellular pathway subverted by some pathogens to promote their own replication. Autophagy, Infection, and the Immune Response provides a unified overview of the roles of cellular autophagy during microbial infection. Introductory chapters ground the reader by delineating the autophagic pathway from a cellular perspective, and by listing assays available for measuring autophagy. Subsequent chapters address virus interactions with autophagy machinery, the various roles of autophagy parasitic infection, and interactions of bacteria with the autophagic pathway. Concluding chapters explore the relationships of autophagy to systemic immune responses, including antigen presentation, ER stress, and production of IFN-gamma. Designed as a resource for those interested in initiating studies on the relationship between autophagy and infection or immunity, Autophagy, Infection, and the Immune Response combines practical state-of the art technique descriptions with an overview of the wide variety of known interactions between pathogens and the autophagic pathway.
- Published
- 2015
39. VCP Associated Inclusion Body Myopathy and Paget Disease of Bone Knock-In Mouse Model Exhibits Tissue Pathology Typical of Human Disease
- Author
-
Badadani, Mallikarjun, Nalbandian, Angele, Watts, Giles D., Vesa, Jouni, Kitazawa, Masashi, Su, Hailing, Tanaja, Jasmin, Dec, Eric, Wallace, Douglas C., Mukherjee, Jogeshwar, Caiozzo, Vincent, Warman, Matthew, and Kimonis, Virginia E.
- Subjects
valosin-containing protein ,frontotemporal dementia ,aaa-atpase ,endoplasmic-reticulum ,cell-death ,autophagic vacuoles ,gene-expression ,mice ,ubiquitin ,p97 - Abstract
Dominant mutations in the valosin containing protein (VCP) gene cause inclusion body myopathy associated with Paget's disease of bone and frontotemporal dementia (IBMPFD). We have generated a knock-in mouse model with the common R155H mutation. Mice demonstrate progressive muscle weakness starting approximately at the age of 6 months. Histology of mutant muscle showed progressive vacuolization of myofibrils and centrally located nuclei, and immunostaining shows progressive cytoplasmic accumulation of TDP-43 and ubiquitin-positive inclusion bodies in quadriceps myofibrils and brain. Increased LC3-II staining of muscle sections representing increased number of autophagosomes suggested impaired autophagy. Increased apoptosis was demonstrated by elevated caspase-3 activity and increased TUNEL-positive nuclei. X-ray microtomography (uCT) images show radiolucency of distal femurs and proximal tibiae in knock-in mice and uCT morphometrics shows decreased trabecular pattern and increased cortical wall thickness. Bone histology and bone marrow derived macrophage cultures in these mice revealed increased osteoclastogenesis observed by TRAP staining suggestive of Paget bone disease. The VCPR155H/+ knock-in mice replicate the muscle, bone and brain pathology of inclusion body myopathy, thus representing a useful model for preclinical studies.
- Published
- 2010
40. Inhibition of Autophagy Attenuated Ethylene Glycol Induced Crystals Deposition and Renal Injury in a Rat Model of Nephrolithiasis
- Author
-
Yunlong Liu, Quan Liu, Xiang Wang, Ziqi He, Derong Li, Xiaofeng Guan, Zhiwei Tao, and Yaoliang Deng
- Subjects
Autophagy ,Autophagic vacuoles ,Calcium oxalate crystals ,Renal tubular cells ,Reactive oxygen species ,Nephrolithiasis ,Dermatology ,RL1-803 ,Diseases of the circulatory (Cardiovascular) system ,RC666-701 ,Diseases of the genitourinary system. Urology ,RC870-923 - Abstract
Background/Aims: Nephrolithiasis is a common and frequently occurring disease, its exact pathogenesis is remains unclear. Emerging data suggest that autophagy plays a vital role in the pathophysiological processes of kidney diseases. Therefore, this study was designed to investigate the potential role of autophagy in the formation of calcium oxalate (CaOx) kidney stones in rat model. Methods: Thirty-two rats were randomly divided into four groups (eight rats/group): untreated control group, stone model group, rapamycin-treated group, chloroquine-treated group. Rat models of CaOx nephrolithiasis was administration of 0.75% ethylene glycol (EG) in their drinking water for 4 weeks. Western blot and transmission electron microscope (TEM) were used to detect the expression of autophagy related protein LC3-II, BECN1 and p62 and autophagic vacuoles respectively. Renal function was evaluated by measuring the levels of serum CRE and BUN. Renal tubular injury markers NGAL and Kim-1 was determined by ELISA kits. Von Kossa staining was used to assess crystal deposits and histological tissue injury. TUNEL staining was employed to assess apoptosis of the renal tubular cell. Results: Compare with the controls, the expression of autophagy related protein LC3-II, BECN1 and number of autophagic vacuoles were increased significantly, whereas the p62 protein level was decreased in the stone model group. The levels of apoptosis, serum CRE and BUN, NGAL and Kim-1 in the stone model group were increased compared with the control group and crystals deposition and renal injury were increased significantly. However, the levels of autophagy, kidney injury and crystal deposition were decreased by chloroquine but increased by rapamycin. Conclusion: These findings suggested that rats were administration of ethylene glycol could lead to the formation of CaOx nephrolithiasis and autophagy activation. Inhibiting autophagy could be an effective therapeutic approach for decreasing the formation of nephrolithiasis.
- Published
- 2018
- Full Text
- View/download PDF
41. Pathological mitochondria in neurons and perivascular astrocytic endfeet of idiopathic normal pressure hydrocephalus patients.
- Author
-
Hasan-Olive, Md Mahdi, Enger, Rune, Hansson, Hans-Arne, Nagelhus, Erlend A., and Eide, Per Kristian
- Subjects
- *
MITOCHONDRIA , *AUTOPHAGY , *MITOCHONDRIAL pathology , *ASTROCYTES , *NERVE endings , *TRANSMISSION electron microscopy , *NEURONS , *NEUROFIBRILLARY tangles - Abstract
Background: A growing body of evidence suggests that the accumulation of amyloid-β and tau (HPτ) in the brain of patients with the dementia subtype idiopathic normal pressure hydrocephalus (iNPH) is associated with delayed extravascular clearance of metabolic waste. Whether also clearance of intracellular debris is affected in these patients needs to be examined. Hypothetically, defective extra- and intra-cellular clearance of metabolites may be instrumental in the neurodegeneration and dementia characterizing iNPH. This study explores whether iNPH is associated with altered mitochondria phenotype in neurons and astrocytes. Methods: Cortical brain biopsies of 9 reference (REF) individuals and 30 iNPH patients were analyzed for subcellular distribution and morphology of mitochondria using transmission electron microscopy. In neuronal soma of REF and iNPH patients, we identified normal, pathological and clustered mitochondria, mitochondria-endoplasmic reticulum contact sites and autophagic vacuoles. We also differentiated normal and pathological mitochondria in pre- and post-synaptic nerve terminals, as well as in astrocytic endfoot processes towards vessels. Results: We found a high prevalence of pathological mitochondria in neuronal soma and pre- and post-synaptic terminals, as well as increased mitochondrial clustering, and altered number of mitochondria-endoplasmic reticulum contact sites in iNPH. Non-fused autophagic vacuoles were more abundant in neuronal soma of iNPH patients, suggestive of cellular clearance failure. Moreover, the length of postsynaptic densities was reduced in iNPH, potentially related to reduced synaptic activity. In astrocytic endfoot processes, we also found increased number, area and area fraction of pathological mitochondria in iNPH patients. The proportion of pathological mitochondria correlated significantly with increasing degree of astrogliosis and reduced perivascular expression of aquaporin-4 (AQP4), assessed by light microscopy immunohistochemistry. Conclusion: Our results provide evidence of mitochondrial pathology and signs of impaired cellular clearance in iNPH patients. The results indicate that iNPH is a neurodegenerative disease with close similarity to Alzheimer's disease. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
42. Characterization of the Cytotoxic Mechanism and Mode of Cell Death Induced by a MEK1/2-selective version of Anthrax Lethal Toxin (PrAg/LFW271A) in Acute Myeloid Leukemia
- Author
-
Mroue, Zeinab and Mroue, Zeinab
- Abstract
Wild-type anthrax lethal toxin (PrAg/LF) demonstrated high potency in inhibiting the MAPK pathway in AML cell lines that rely on this pathway for survival. PrAg/LF is a binary toxin consisting of protective antigen (PrAg), that serves as the tumor specific delivery protein, and the wild-type effector LF, which inhibits three crucial MAPK pathways —ERK, P38, and JNK—by cleaving MEK1/2, MEK3/6, and MEK4/7, respectively. Although PrAg/LF exhibits tumor selectivity, its in vivo toxicity restricts its clinical application. Based on the finding that the potency of LF in inhibiting tumor growth is primarily attributed to its MEK1/2 inactivation properties, a novel MEK1/2-selective version of Anthrax Lethal Toxin (PrAg/LFW271A) that spares the non-specific inhibition of other MKKs such as the p38 and JNK pathways, was developed. In this study, we aimed to examine the anti-tumor activity, the cytotoxic mechanism, and the mode of cell death of the new variant PrAg/LFW271A. The results from the cytotoxicity assays exhibit similar anti-tumor activity between PrAg/LF and PrAg/LFW271A in 4 out of 7 human AML cell lines. The ERK pathway examination revealed inhibition of this pathway in sensitive and resistant cells. This indicates the reliance of the sensitive cells on the ERK pathway, while the resistance mechanism might rely on other pathways for survival. Additionally, staining for Annexin V/propidium iodide following treatment showed no evidence for apoptotic death following ERK pathway inhibition. Furthermore, we showed activation of autophagy in a number of cell lines following treatment with both the wild-type and MEK1/2-specific version of LF. Inhibition of autophagy using CQ, abrogated both the LF- and the LFW271A-mediated cell death in a number of AML cell line, indicating that, in these cells, the inhibition of the MAPK pathway leads to autophagy-mediated cell death (death by autophagy). In this study, we have shown that PrAg/LFW271A maintained the same anti-tumor acti
- Published
- 2023
43. Sumoylation and phosphorylation of PTEN boosts and curtails autophagy respectively by influencing cell membrane localisation.
- Author
-
De, Debojyoti, Ghosh, Ginia, and Karmakar, Parimal
- Subjects
- *
AUTOPHAGY , *POST-translational modification , *PI3K/AKT pathway , *PHOSPHORYLATION - Abstract
Autophagy is involved in the entirety of cellular survival, homeostasis and death which becomes more self-evident when its dysregulation is implicated in several pathological conditions. PTEN positively regulates autophagy and like other proteins undergo post-translational modifications. It is crucial to investigate the relationship between PTEN and autophagy as it is generally observed to be negligible in PTEN deficient cancer cells. Here, we have shown that such modifications of PTEN namely sumoylation and phosphorylation upregulates and downregulates autophagy respectively. Transfection of plasmid containing full length PTEN in PTEN-negative prostate cancer cell line PC3, induced autophagy on further starvation. When a sumoylation-deficient mutant of PTEN was transfected and cells were put under similar starvation, a decline in autophagy was observed. On the other hand, cells transfected with phosphorylation-deficient mutant of PTEN showed elevated expression of autophagy. Contrarily, transfection with phosphorylation-mimicking mutant caused reduced expression of autophagy. On further analysis, it was detected that PTEN's association with the plasma membrane was under positive and negative influence from its sumoylation and phosphorylation respectively. This association is integral as it is the foremost site for PTEN to oppose PI3K/AKT pathway and consequently upregulate autophagy. Thus, this study indicates that sumoylation and phosphorylation of PTEN can control autophagy via its cell membrane association. [Display omitted] • The modulation of autophagy by the post-translational modifications of its fundamental regulator PTEN is studied here. • Sumoylation of PTEN positively regulates autophagy, detected by sumoylation-deficient mutant PTEN (K254R) transfection. • Phosphorylation of PTEN reduces autophagy, revealed by phosphorylation mutants PTEN (A4), PTEN (E4) transfection. • Autophagy increases and decreases PTEN's sumoylation and phosphorylation levels respectively, in normal and cancer cells. • Sumoylation and phosphorylation tune PTEN's cell membrane localization and consequently autophagy. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
44. Autophagy: Cancer, Other Pathologies, Inflammation, Immunity, Infection, and Aging : Volume 3 - Role in Specific Diseases
- Author
-
M. A. Hayat and M. A. Hayat
- Subjects
- Autophagic vacuoles
- Abstract
Understanding the importance and necessity of the role of autophagy in health and disease is vital for the studies of cancer, aging, neurodegeneration, immunology, and infectious diseases. Comprehensive and up-to-date, this book offers a valuable guide to these cellular processes whilst encouraging researchers to explore their potentially important connections. Volume 3 explores the role of autophagy in specific diseases and developments, including: Crohn's Disease, Gaucher Disease, Huntington's Disease, HCV infection, osteoarthritis, and liver injury. A full section is devoted to in-depth exploration of autophagy in tumor development and cancer. Finally, the work explores the relationship between autophagy and apoptosis, with attention to the ways in which autophagy regulates apoptosis, and the ways in which autophagy has been explored in Lepidoptera, elucidating the use of larval midgut as a model for such exploration. From these well-developed foundations, researchers, translational scientists, and practitioners may work to better implement more effective therapies against some of the most devastating human diseases. Volumes in the Series
- Published
- 2014
45. Autophagy: Cancer, Other Pathologies, Inflammation, Immunity, Infection, and Aging : Volume 5 - Role in Human Diseases
- Author
-
M. A. Hayat and M. A. Hayat
- Subjects
- Immunity, Autophagic vacuoles
- Abstract
Understanding the importance and necessity of the role of autophagy in health and disease is vital for the studies of cancer, aging, neurodegeneration, immunology, and infectious diseases. Comprehensive and up-to-date, this book offers a valuable guide to these cellular processes whilst inciting researchers to explore their potentially important connections. Volume 5 comprehensively describes the role of autophagy in human diseases, delivering coverage of the antitumor and protumor roles of autophagy; the therapeutic inhibition of autophagy in cancer; and the duality of autophagy's effects in various cardiovascular, metabolic, and neurodegenerative disorders. In spite of the increasing importance of autophagy in the various pathophysiological conditions mentioned above, this process remains underestimated and overlooked. As a consequence, its role in the initiation, stability, maintenance, and progression of these and other diseases remains poorly understood. This book is an asset to newcomers as a concise overview of the diverse disease implications of autophagy, while serving as an excellent reference for more experienced scientists and clinicians looking to update their knowledge. Volumes in the Series
- Published
- 2014
46. Autophagy: Cancer, Other Pathologies, Inflammation, Immunity, Infection, and Aging : Volume 4 - Mitophagy
- Author
-
M. A. Hayat and M. A. Hayat
- Subjects
- Autophagic vacuoles
- Abstract
Autophagy: Cancer, Other Pathologies, Inflammation, Immunity, Infection and Aging, Volume 4 - Mitophagy presents detailed information on the role of mitophagy, the selective autophagy of mitochondria, in health and disease, by delivering an in-depth treatment of the molecular mechanisms involved in mitophagy initiation and execution, as well as the role of mitophagy in Parkinson's Disease, cardiac aging, and skeletal muscle atrophy. The most current understanding of the proteins and pathways involved in mitophagy are covered, with specific attention to Nix and Bnip3, PINK1/Parkin, Atg32, and FUNDC1. The role of mitophagy in cancer, neurodegeneration, aging, infection, and inflammation is also discussed providing essential insights into the pathogenesis of a variety of mitochondria dysfunction-related diseases. This book is an asset to newcomers as a concise overview of the current knowledge on mitophagy, while serving as an excellent update reference for more experienced scientists working on other aspects of autophagy. From these well-developed foundations, researchers, translational scientists, and practitioners may work to better implement more effective therapies against some of the most devastating human diseases. Volumes in the Series
- Published
- 2014
47. Autophagy in Alzheimer’s disease: A Cleaning Service Out-of-order?
- Author
-
Correia, Sónia C., Moreira, Paula I., Perry, George, Kostrzewa, Richard, Series editor, Archer, Trevor, Series editor, and Fuentes, José M., editor
- Published
- 2015
- Full Text
- View/download PDF
48. Autophagy and Tau Protein
- Author
-
Tadanori Hamano, Soichi Enomoto, Norimichi Shirafuji, Masamichi Ikawa, Osamu Yamamura, Shu-Hui Yen, and Yasunari Nakamoto
- Subjects
autophagy ,Alzheimer’s disease ,tau protein ,amyloid β protein ,autophagic vacuoles ,mTORC1 ,Biology (General) ,QH301-705.5 ,Chemistry ,QD1-999 - Abstract
Neurofibrillary tangles, which consist of highly phosphorylated tau protein, and senile plaques (SPs) are pathological hallmarks of Alzheimer’s disease (AD). In swollen axons, many autophagic vacuoles are observed around SP in the AD brain. This suggests that autophagy function is disturbed in AD. We used a neuronal cellular model of tauopathy (M1C cells), which harbors wild type tau (4R0N), to assess the effects of the lysosomotrophic agent NH4Cl, and autophagy inhibitors chloroquine and 3 methyladenine (3MA). It was found that chloroquine, NH4Cl and 3MA markedly increased tau accumulation. Thus, autophagy lysosomal system disturbances disturbed the degradation mechanisms of tau protein. Other studies also revealed that tau protein, including aggregated tau, is degraded via the autophagy lysosome system. Phosphorylated and C terminal truncated tau were also reported to disturb autophagy function. As a therapeutic strategy, autophagy upregulation was suggested. Thus far, as autophagy modulators, rapamycin, mTOCR1 inhibitor and its analogues, lithium, metformin, clonidine, curcumin, nicotinamide, bexaroten, and torehalose have been proposed. As a therapeutic strategy, autophagic modulation may be the next target of AD therapeutics.
- Published
- 2021
- Full Text
- View/download PDF
49. Probleme der cellulären Autophagie : Morphologische, enzymcytochemische und quantitative Untersuchungen an normalen und alterierten Leberepithelien der Ratte
- Author
-
U. Pfeifer and U. Pfeifer
- Subjects
- Autophagic vacuoles, Liver
- Published
- 2013
50. Autophagy: Cancer, Other Pathologies, Inflammation, Immunity, Infection, and Aging : Volume 1 - Molecular Mechanisms
- Author
-
M. A. Hayat and M. A. Hayat
- Subjects
- Autophagic vacuoles
- Abstract
Understanding the importance and necessity of the role of autophagy in health and disease is vital for the studies of cancer, aging, neurodegeneration, immunology, and infectious diseases. Comprehensive and forward thinking, these books offer a valuable guide to both cellular processes while inciting researchers to explore their potentially important connections. Considering that autophagy is associated with numerous biological processes, including cellular development and differentiation, cancer (both antitumor and protumor functions), immunity, infectious diseases, inflammation, maintenance of homeostasis, response to cellular stress, and degenerative diseases such as Alzheimer's, Parkinson's, Huntington's, amyotrophic lateral sclerosis, and prion diseases, there is a great need to understanding its role. Cell homeostasis is achieved by balancing biosynthesis and cellular turnover. In spite of the increasing importance of autophagy in various pathophysiological situations (conditions) mentioned above, this process remains underestimated and overlooked. As a consequence, its role in the initiation, stability, maintenance, and progression of these and other diseases (e.g., autoimmune disease) remains poorly understood. Volumes in the Series
- Published
- 2013
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.